Reverdia, the joint venture between Royal DSM and Roquette Frères, has been formally approved by the relevant regulatory authorities.

Reverdia aims to build on its emerging leadership position for bio-based succinic acid through its proprietary production technology and by ensuring reliable supply to meet the evolving market demands. Reverdia combines DSM's expertise in Materials Sciences, and biotechnology together with Roquette's know-how in plant-based raw material processing.

Bio-based succinic acid is derived from non-fossil feedstock and produced with sustainable production technologies that minimize carbon footprint. It is a building block that can be used in the manufacture of polymers, resins and many other products. Key applications include footwear, packaging and paints.

The new facility, scheduled to be operational by the end of Q3 2012 will have a capacity of about 10 kt, and is located on the Roquette site in Cassano Spinola, Italy. The proximity to the port of Genoa ensures efficient global logistics.